Get the Stockscreener App
1.47
6.14%
+0.085
Interpace Biosciences Inc. Stock (IDXG) Forecast
The Interpace Biosciences Inc. (IDXG) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $3.9935, representing a +171.67% increase from the current price of $1.47. The highest analyst price target is $7.7788, and the lowest is $0.2082.
Based on our technical indicators, the current sentiment is neutral and IDXG could range between $13.68 and $0.4465 in 2025. This suggests that investors should exercise caution when entering new positions on IDXG, as the market is likely to remain volatile in the near term.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IDXG Price Target
Average 3.9935
(+171.67% Upside)
Long-term IDXG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Our analysts are offering long term price forecasts for Interpace Biosciences Inc. In 2050, the median target price for IDXG is $87.33, with a high estimate of $156.72 and a low estimate of $44.81. The median estimate represents a +5,841% increase from the last price of $1.47. Below is our long term IDXG Price forecast table with detailed price target for each year.
| Year | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| 2024 | $5.4893 | $0.1999 | $7.7788 | +273.42% |
| 2025 | $11.14 | $0.4465 | $13.68 | +657.90% |
| 2026 | $17.18 | $2.4175 | $19.58 | +1,068% |
| 2027 | $23.12 | $4.3885 | $25.48 | +1,473% |
| 2028 | $30.31 | $6.3595 | $31.38 | +1,962% |
| 2029 | $35.46 | $8.3305 | $35.32 | +2,312% |
| 2030 | $11.50 | $10.30 | $40.22 | +682.41% |
| 2035 | $38.94 | $18.70 | $69.72 | +2,549% |
| 2040 | $81.82 | $27.70 | $99.22 | +5,466% |
| 2045 | $37.60 | $36.70 | $126.37 | +2,458% |
| 2050 | $87.33 | $44.81 | $156.72 | +5,841% |
Interpace Biosciences Inc. Stock (IDXG) Year by Year Forecast
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2024
For Interpace Biosciences Inc. Stock (IDXG) price forecast for 2024, the average price target for Interpace Biosciences Inc. Stock is $3.9894 with a high forecast of $7.7788 and a low forecast of $0.1999. The average IDXG price prediction of 2024 represents a +171.38% increase from the last price of $1.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $3.9682 | $4.1952 | $4.3534 | +169.95% |
| June, 2024 | $3.2621 | $3.5129 | $3.7545 | +121.91% |
| July, 2024 | $2.8789 | $2.7997 | $3.0813 | +95.84% |
| August, 2024 | $1.825 | $2.03 | $2.4081 | +24.15% |
| September, 2024 | $0.7682 | $0.2082 | $1.5392 | -47.74% |
| October, 2024 | $5.11 | $0.539 | $4.97 | +247.62% |
| November, 2024 | $6.7441 | $6.924 | $7.7788 | +358.78% |
| December, 2024 | $5.4893 | $5.7793 | $6.469 | +273.42% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2025
Interpace Biosciences Inc. Stock (IDXG) is expected to reach an average price of $7.0623 in 2025, with a high prediction of $13.68 and a low estimate of $0.4465. This indicates an +380.43% rise from the last recorded price of $1.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.7184 | $4.7246 | $5.1769 | +220.98% |
| February, 2025 | $3.2536 | $3.5936 | $4.1622 | +121.33% |
| March, 2025 | $2.4689 | $2.5189 | $2.9874 | +67.95% |
| April, 2025 | $1.0234 | $0.4465 | $1.6003 | -30.38% |
| May, 2025 | $9.6537 | $8.145 | $10.73 | +556.71% |
| June, 2025 | $8.3903 | $8.4073 | $9.2321 | +470.77% |
| July, 2025 | $6.891 | $6.991 | $7.7557 | +368.78% |
| August, 2025 | $5.2131 | $5.2581 | $6.3994 | +254.63% |
| September, 2025 | $3.7867 | $4.3464 | $4.7515 | +157.60% |
| October, 2025 | $2.4536 | $1.432 | $3.4752 | +66.91% |
| November, 2025 | $12.54 | $11.18 | $13.68 | +753.34% |
| December, 2025 | $11.14 | $11.18 | $12.12 | +657.90% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2026
The 2026 price forecast for Interpace Biosciences Inc. Stock (IDXG) stands at an average of $11.00. Projections range from a high of $19.58 to a low of $2.4175, signifying an +648.12% increase from the previous price of $1.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.9012 | $9.0012 | $10.58 | +505.53% |
| February, 2026 | $7.2333 | $7.5733 | $8.3243 | +392.06% |
| March, 2026 | $5.6854 | $6.0104 | $6.7814 | +286.76% |
| April, 2026 | $2.4075 | $2.4175 | $5.0084 | +63.78% |
| May, 2026 | $15.99 | $3.4005 | $16.63 | +987.43% |
| June, 2026 | $14.06 | $14.29 | $15.14 | +856.38% |
| July, 2026 | $11.46 | $11.52 | $13.50 | +679.86% |
| August, 2026 | $9.4244 | $9.7644 | $10.85 | +541.11% |
| September, 2026 | $7.4749 | $7.6799 | $8.837 | +408.49% |
| October, 2026 | $3.393 | $3.403 | $6.8475 | +130.82% |
| November, 2026 | $19.61 | $4.3006 | $19.58 | +1,234% |
| December, 2026 | $17.18 | $17.36 | $18.67 | +1,068% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2027
For 2027, the average price target for Interpace Biosciences Inc. Stock (IDXG) is $14.93, with a high forecast of $25.48 and a low forecast of $4.3885. This indicates an +915.81% increase from the last price of $1.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $14.17 | $14.51 | $16.56 | +863.76% |
| February, 2027 | $12.08 | $12.12 | $13.56 | +721.51% |
| March, 2027 | $9.2451 | $9.5851 | $11.18 | +528.92% |
| April, 2027 | $4.5863 | $5.1463 | $8.6373 | +211.99% |
| May, 2027 | $20.29 | $4.3885 | $20.14 | +1,280% |
| June, 2027 | $20.43 | $20.55 | $22.53 | +1,290% |
| July, 2027 | $16.82 | $17.11 | $19.66 | +1,044% |
| August, 2027 | $14.35 | $14.35 | $16.08 | +876.11% |
| September, 2027 | $11.55 | $11.59 | $13.64 | +685.45% |
| October, 2027 | $8.2503 | $8.3003 | $10.74 | +461.25% |
| November, 2027 | $5.7374 | $5.374 | $6.1008 | +290.30% |
| December, 2027 | $23.12 | $23.24 | $25.48 | +1,473% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2028
Interpace Biosciences Inc. Stock (IDXG) is estimated to achieve an average price of $18.87 in 2028, with a high projection of $31.38 and a low estimate of $6.3595. This suggests an +1,184% rise from the preceding price of $1.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $20.15 | $20.17 | $22.27 | +1,271% |
| February, 2028 | $16.94 | $17.04 | $19.09 | +1,053% |
| March, 2028 | $13.13 | $13.17 | $16.02 | +793.16% |
| April, 2028 | $9.9952 | $10.55 | $12.24 | +579.94% |
| May, 2028 | $7.0009 | $6.3595 | $9.2566 | +376.25% |
| June, 2028 | $26.44 | $26.36 | $28.43 | +1,699% |
| July, 2028 | $23.33 | $23.36 | $25.58 | +1,487% |
| August, 2028 | $19.85 | $19.91 | $22.34 | +1,250% |
| September, 2028 | $15.58 | $15.92 | $18.89 | +959.64% |
| October, 2028 | $12.32 | $12.65 | $14.70 | +738.15% |
| November, 2028 | $7.335 | $7.345 | $11.22 | +398.98% |
| December, 2028 | $30.31 | $7.901 | $31.38 | +1,962% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2029
The 2029 price forecast for Interpace Biosciences Inc. Stock (IDXG) is $21.83 on average, with a high prediction of $35.32 and a low estimate of $8.3305. This represents an +1,385% increase from the previous price of $1.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $26.67 | $26.90 | $29.04 | +1,714% |
| February, 2029 | $22.89 | $23.23 | $25.69 | +1,457% |
| March, 2029 | $18.19 | $18.53 | $21.94 | +1,138% |
| April, 2029 | $14.54 | $14.74 | $17.18 | +888.93% |
| May, 2029 | $8.8698 | $9.4298 | $13.48 | +503.39% |
| June, 2029 | $34.36 | $8.3305 | $34.33 | +2,237% |
| July, 2029 | $30.22 | $30.40 | $33.00 | +1,956% |
| August, 2029 | $25.07 | $25.41 | $29.17 | +1,606% |
| September, 2029 | $21.27 | $21.31 | $24.04 | +1,347% |
| October, 2029 | $16.73 | $17.07 | $19.95 | +1,038% |
| November, 2029 | $9.9407 | $10.50 | $15.70 | +576.24% |
| December, 2029 | $35.46 | $9.316 | $35.32 | +2,312% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2030
Interpace Biosciences Inc. Stock (IDXG) is expected to reach an average price of $25.26 in 2030, with a high forecast of $40.22 and a low forecast of $10.30. This signifies an +1,619% surge from the last price of $1.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $33.89 | $34.01 | $37.27 | +2,206% |
| February, 2030 | $29.56 | $29.57 | $32.70 | +1,911% |
| March, 2030 | $23.97 | $23.97 | $28.15 | +1,531% |
| April, 2030 | $19.46 | $19.51 | $22.84 | +1,224% |
| May, 2030 | $14.03 | $14.08 | $18.23 | +854.54% |
| June, 2030 | $10.50 | $10.30 | $10.70 | +614.39% |
| July, 2030 | $37.55 | $37.93 | $40.22 | +2,455% |
| August, 2030 | $31.91 | $31.93 | $36.36 | +2,071% |
| September, 2030 | $26.99 | $27.09 | $30.42 | +1,736% |
| October, 2030 | $22.25 | $22.59 | $25.65 | +1,414% |
| November, 2030 | $16.20 | $16.76 | $21.03 | +1,002% |
| December, 2030 | $11.50 | $11.29 | $15.04 | +682.41% |
3.04%
25.72%
Cap:
|
Volume (24h):